Stephen J. Schueler, M.D.

Overview Incidence Risk Factors Symptoms Evaluation Treatment diet questions for doctor specialist Home Care diet taking control warning signs Prevention vaccine Outlook Complications Transmission Anatomy

Viral Hepatitis B Overview

Another name for Viral Hepatitis B is Hepatitis B.

What is hepatitis B?
A person with hepatitis B has inflammation of the liver from an infection by the hepatitis B virus. Hepatitis B is spread by exposure to the blood of someone who is infected. It is also spread through sexual contact. In most cases, the infection resolves within 4 months. About 1 out of 10 people remain infected with the hepatitis B virus for the rest of their lives.

What are the symptoms of hepatitis B?
Initial symptoms of hepatitis B may include weakness, fatigue, fever, and right upper abdominal pain. In some cases, symptoms of hepatitis B also include jaundice, brown urine, and itching.

How does the doctor treat hepatitis B?
Treatment for hepatitis B may include a liver disease diet, antiviral medications, and medications to control nausea and itching. Those with severe hepatitis B may be candidates for liver transplant.

Continue to Viral Hepatitis B Incidence

Last Updated: Dec 15, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Viral Hepatitis B References
  1. Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs. 2003;63(23):2625-49. [14636084]
  2. Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005 Sep 28;74(1):39-45. [16098410]
  3. Papatheodoridis GV, Hadziyannis SJ. Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther. 2004 Jan 1;19(1):25-37. [14687164]
  4. Rich JD, Ching CG, Lally MA, Gaitanis MM, Schwartzapfel B, Charuvastra A, Beckwith CG, Flanigan TP. A review of the case for hepatitis B vaccination of high-risk adults. Am J Med. 2003 Mar;114(4):316-8. [12681460]
  5. Rischitelli G, Harris J, McCauley L, Gershon R, Guidotti T. The risk of acquiring hepatitis B or C among public safety workers: a systematic review. Am J Prev Med. 2001 May;20(4):299-306. [11331121]
  6. Robins GW, Scott LJ, Keating GM. Peginterferon-alpha-2a (40kD): a review of its use in the management of patients with chronic hepatitis B. Drugs. 2005;65(6):809-25. [15819595]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.